"Nagy, P." . "Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers"@en . "Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers" . . "NO - Norsk\u00E9 kr\u00E1lovstv\u00ED" . . "Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers" . "Tulassay, Z." . . . . "Objective. To evaluate endoscopic and histological findings after Helicobacter pylori eradication therapy in gastric ulcer (GU) patients after 12 months' follow-up. Material and methods. A total of 401 GU patients were randomized to receive either twice-daily (b.i.d.) esomeprazole 20 mg+amoxicillin 1000 mg+clarithromycin 500 mg (EAC) for 1 week followed by placebo for 3 weeks, EAC followed by once-daily (o.d.) esomeprazole 20 mg for 3 weeks or esomeprazole 20 mg b.i.d. plus placebo antibiotics for 1 week followed by esomeprazole 20 mg o.d. for 3 weeks. Endoscopy with biopsy was performed ... etc."@en . . "11"^^ . "Stolte, M." . . "17110" . "Malfertheiner, P." . "Engstrand, L." . "RIV/61988987:17110/10:A11011CZ" . "[8E248E73A51E]" . "Wong, B." . "45" . "1"^^ . "Hersz\u00E9nyi, L." . "Tchernev, K." . . . "293836" . "Wrangstadt, M." . "Eklund, S." . "13"^^ . "D\u00EDt\u011B, Petr" . "Eradication therapy; esomeprazole; gastric ulcer; Helicobacter pylori; histology"@en . . "Butruk, E." . . "Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers"@en . "Gottlow, M." . "SCAND J GASTROENTERO" . "RIV/61988987:17110/10:A11011CZ!RIV11-MSM-17110___" . "0036-5521" . . . "Objective. To evaluate endoscopic and histological findings after Helicobacter pylori eradication therapy in gastric ulcer (GU) patients after 12 months' follow-up. Material and methods. A total of 401 GU patients were randomized to receive either twice-daily (b.i.d.) esomeprazole 20 mg+amoxicillin 1000 mg+clarithromycin 500 mg (EAC) for 1 week followed by placebo for 3 weeks, EAC followed by once-daily (o.d.) esomeprazole 20 mg for 3 weeks or esomeprazole 20 mg b.i.d. plus placebo antibiotics for 1 week followed by esomeprazole 20 mg o.d. for 3 weeks. Endoscopy with biopsy was performed ... etc." . "9" . . . "V" . .